Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Other financing activities (2018 - 2024)

Health Catalyst (HCAT) has disclosed Other financing activities for 2 consecutive years, with -$848000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Other financing activities changed N/A year-over-year to -$848000.0, compared with a TTM value of -$848000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $2.2 million, changed N/A over the prior year.
  • Other financing activities was -$848000.0 for Q4 2024 at Health Catalyst, down from $203000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at -$848000.0 in Q4 2024 and bottomed at -$848000.0 in Q4 2024.